Neuroscience
From EurekaAlert:
UCSF-Pfizer partnership yields projects aimed at clinical trials
26 October 2011
Read the full article
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Will There Be Biotechs "emerging From The Rubble At Sandwich"?
Investors ready to craft new biotechs out of Pfizer's discards February 9, 2011 — 8:47am ET By John Carroll FierceBiotech Read the article...
- Alzheimer Disease: Dimebon Results, Part Ii
From The New York Times: Hopes for Alzheimer’s Drug Are Dashed By ANDREW POLLACK Published: March 4, 2010 "The drug, called Dimebon, failed in its first late-stage clinical trial, dealing a blow to patients with Alzheimer’s and the companies developing...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Clinical Trials: Social Networking For Recruitment And Feedback
Pharmafocus reported earlier in the week about a plan by Pfizer to roll out some social networking options for patients considering clinical-trial participation: Pfizer to develop online community to find new trials patients Monday , August 24, 2009 Read...
Neuroscience
UC San Francisco-Pfizer Drug Development Partnership
From EurekaAlert:
UCSF-Pfizer partnership yields projects aimed at clinical trials
26 October 2011
Read the full article
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Will There Be Biotechs "emerging From The Rubble At Sandwich"?
Investors ready to craft new biotechs out of Pfizer's discards February 9, 2011 — 8:47am ET By John Carroll FierceBiotech Read the article...
- Alzheimer Disease: Dimebon Results, Part Ii
From The New York Times: Hopes for Alzheimer’s Drug Are Dashed By ANDREW POLLACK Published: March 4, 2010 "The drug, called Dimebon, failed in its first late-stage clinical trial, dealing a blow to patients with Alzheimer’s and the companies developing...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Clinical Trials: Social Networking For Recruitment And Feedback
Pharmafocus reported earlier in the week about a plan by Pfizer to roll out some social networking options for patients considering clinical-trial participation: Pfizer to develop online community to find new trials patients Monday , August 24, 2009 Read...